ALS-205 / Alsonex 
Welcome,         Profile    Billing    Logout  
 0 Diseases   1 Trial   1 Trial   56 News 
2 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
ALS-205 / Alsonex
ACTRN12619001639112: A randomised, double-blind, placebo-controlled, phase 1 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple ascending doses of PMX205 in healthy volunteers.

Completed
1
54
 
Alsonex Pty Ltd, Alsonex Pty Ltd
Motor Neuron Disease, Parkinson's Disease
 
 
ACTRN12622000927729: An open-label, phase 1b study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of a single dose of PMX205 in patients with amyotrophic lateral sclerosis

Completed
1
8
 
Alsonex Pty Ltd, Alsonex Pty Ltd
Amyotrophic Lateral Sclerosis, Motor Neuron Disease, Parkinson's Disease
 
 

Download Options